Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Travelling with kids: how can you minimise jet lag with your little ones?

Travelling with kids isn’t easy and jet lag can be particularly painful. There are ways to make it easier.

Travelling with children can be a challenging experience, especially when crossing multiple time zones. Jet lag, a temporary misalignment of the internal body clock (circadian rhythm) with the local time, can cause fatigue and sleep disturbances for both adults and kids. While jet lag is typically associated with airplane travel, the effects can be exacerbated when traveling east, as it involves "losing" time, making it harder for the body to adjust to nighttime sleep.

Conversely, traveling west may make it easier to stay awake later without too much difficulty falling asleep earlier.

Kids often exhibit similar jet lag symptoms, such as difficulty sleeping, crankiness, loss of appetite, and nausea. However, research suggests that children may experience fewer adverse effects due to their higher production of melatonin, the hormone responsible for inducing sleepiness. The aging process, however, typically decreases our tolerance to jet lag, but this evidence is largely based on comparisons of young and older adults rather than children.

To minimize jet lag before traveling, it's advisable to gradually adjust one's sleep schedule in the days leading up to departure, exposing oneself to morning light, and maintaining consistent meal and bedtime routines. Once at your destination, the most effective remedy is exposure to natural daylight, which can shift the body clock earlier in the morning and later in the afternoon or evening.

Consistency with meal times and bedtime routines will also aid the adjustment process. While various apps and supplements claim to help with jet lag, most rely on similar principles and lack the necessary personalization. Moreover, melatonin supplements should be used with caution or under professional guidance to avoid potential complications.

Written by urgent.news from The Conversation AU's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at theconversation.com →

More in Health & Medicine

Celltrion’s Remsima Takes No. 1 Spot in Japan’s Infliximab Market After 11 Years

Celltrion’s infliximab biosimilar Remsima has become the most prescribed infliximab product in Japan, 11 years after entering a market where biosimilars have traditionally faced limited price-driven…

  • Celltrion's Remsima leads Japan's infliximab market with 48% share since 2015
  • Remsima's success in Japan attributed to physicians' prescribing experience and sales capabilities
  • Celltrion plans to launch subcutaneous Remsima SC in Japan in 2027

More from Thursday 17 September →